CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Ferring Pharmaceuticals Inc. v. Serenity Pharmaceuticals, LLC

1:17-cv-00479

Overview

Case Number 1:17-cv-00479
Filing Date 2017-04-28
Status Terminated
Termination Date 2017-12-18
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 28:2201 Declaratory Judgment
Jury Demand None

Parties

Defendant

Allergan, Inc. Operating Company

Represented By

1 Attorneys Listed

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Reprise Biopharmaceutics, LLC Operating Company

Represented By

1 Attorneys Listed

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Serenity Pharmaceuticals, LLC Operating Company

Represented By

4 Attorneys Listed

Shehla Wynne

Email: swynne@jonesday.com

James Sottile , IV

Email: jsottile@jonesday.com

Christopher J. Harnett

Email: CHarnett@jonesday.com

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Plaintiff

Ferring International Center S.A. Operating Company

Represented By

6 Attorneys Listed

Keats A. Quinalty

Email: Keats.Quinalty@wbd-us.com

Joshua A. Davis

Email: Joshua.davis@wbd-us.com

John W Cox

Email: john.cox@wbd-us.com

Daniel Marcus Attaway

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4365

1313 North Market Street, Suite 1200

Dana Kathryn Severance

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4329
Fax: +1 (302) 661-7710

1313 North Market Street, Suite 1200

Mary W. Bourke

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320

1313 North Market Street, Suite 1200

Ferring B.V. NPE (Individual / Inventor)

Represented By

6 Attorneys Listed

Keats A. Quinalty

Email: Keats.Quinalty@wbd-us.com

Joshua A. Davis

Email: Joshua.davis@wbd-us.com

John W Cox

Email: john.cox@wbd-us.com

Daniel Marcus Attaway

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4365

1313 North Market Street, Suite 1200

Dana Kathryn Severance

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4329
Fax: +1 (302) 661-7710

1313 North Market Street, Suite 1200

Mary W. Bourke

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320

1313 North Market Street, Suite 1200

Ferring Pharmaceuticals Inc. Operating Company

Represented By

6 Attorneys Listed

Keats A. Quinalty

Email: Keats.Quinalty@wbd-us.com

Joshua A. Davis

Email: Joshua.davis@wbd-us.com

John W Cox

Email: john.cox@wbd-us.com

Daniel Marcus Attaway

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4365

1313 North Market Street, Suite 1200

Dana Kathryn Severance

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4329
Fax: +1 (302) 661-7710

1313 North Market Street, Suite 1200

Mary W. Bourke

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320

1313 North Market Street, Suite 1200

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 1 proceeding
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): GB 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (1 found):
U.S. Courts: 1
U.S. District Court 2017-12-20
1:17-cv-09922

Ferring Pharmaceuticals Inc. v. Serenity Pharmaceuticals, LLC

Asserted Patent
Status: NYSD
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

3 Patents

There are 3 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7405203
Pharmaceutical compositions including low dosages of desmopressin
Filed: 2007-05-04
Issued: 2008-07-29
Expiring Soon (164 days)
Expires: 2027-05-04
US7579321
Pharmaceutical compositions including low dosages of desmopressin
Filed: 2008-07-15
Issued: 2009-08-25
Active (1.6 yrs remaining)
Expires: 2028-07-15
US7799761
Pharmaceutical compositions including low dosages of desmopressin
Filed: 2003-11-12
Issued: 2010-09-21
Expired (Term Ended) +319d PTA
Expires: 2024-09-26

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Narrowing Window — Imminent expiration makes injunctive relief unlikely to be granted.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

26

Dispositive

23

Granted

1

Denied

0

Pending / Review

22

Motions by Category

Procedural / Extension Motion 3 Motion to Dismiss (FRCP 12(b)(6)) 10 Motion to Dismiss 13

Key Dispositive Motions & Rulings

Motion to Dismiss Pending / Under Review
[SEALED] REPLY BRIEF re 46 MOTION for Leave to File a Sur-Reply in Response to Serenity and Reprise's Reply Brief in Support of Their Motion to Dismiss Ferring'...
Entry #51 • 2017-10-03 Document →
Motion to Dismiss Pending / Under Review
[SEALED] MEMORANDUM in Opposition re 46 MOTION for Leave to File a Sur-Reply in Response to Serenity and Reprise's Reply Brief in Support of Their Motion to Dis...
Entry #49 • 2017-09-28 Document →
Motion to Dismiss Pending / Under Review
REDACTED VERSION of 46 MOTION for Leave to File a Sur-Reply in Response to Serenity and Reprise's Reply Brief in Support of Their Motion to Dismiss Ferring's Am...
Entry #48 • 2017-09-21 Document →
Motion to Dismiss Pending / Under Review
STATEMENT re 46 MOTION for Leave to File a Sur-Reply in Response to Serenity and Reprise's Reply Brief in Support of Their Motion to Dismiss Ferring's Amended C...
Entry #47 • 2017-09-18 Document →
Motion to Dismiss Pending / Under Review
[SEALED] MOTION for Leave to File a Sur-Reply in Response to Serenity and Reprise's Reply Brief in Support of Their Motion to Dismiss Ferring's Amended Complain...
Entry #46 • 2017-09-14 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
[SEALED] REPLY BRIEF re 25 MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter MOTION to Dismiss for Lack of Jurisdiction Over the Person MOTION ...
Entry #42 • 2017-09-06 Document →

Docket Entries

(99 total)
Pleading / Complaint

COMPLAINT FOR DECLARATORY JUDGMENT filed against Allergan, Inc., Reprise Biopharmaceutics, LLC, Serenity Pharmaceuticals, LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2130219.) - filed by Ferring Pharmaceuticals Inc., Ferring International Center S.A., Ferring B.V. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Civil Cover Sheet)(ceg) (Entered: 04/28/2017)

Entry #1 • 2017-04-28
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) (Entered: 04/28/2017)

Entry #2 • 2017-04-28
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,405,203 C1; US 7,579,321 B2; US 7,799,761 B2. (ceg) (Entered: 04/28/2017)

Entry #3 • 2017-04-28
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Ferring Holding S.A. for Ferring B.V., Ferring International Center S.A.; Corporate Parent Ferring Holding Inc., Corporate Parent Ferring B.V. for Ferring Pharmaceuticals Inc. filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc. (ceg) (Entered: 04/28/2017)

Entry #4 • 2017-04-28
1

Summons Issued with Magistrate Consent Notice attached as to Allergan, Inc. on 4/28/2017; Reprise Biopharmaceutics, LLC on 4/28/2017; Serenity Pharmaceuticals, LLC on 4/28/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg)

Entry #5 • 2017-04-28
1
No Actions

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc